| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2122519 | European Journal of Cancer | 2013 | 10 Pages |
Abstract
CD4+ lymphopaenia was associated with reduced OS in MBC patients regardless of the chemotherapy line. Decreased levels of plasmatic CCL22 may contribute to CD4+ lymphopaenia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Olivier Trédan, Manuarii Manuel, Gilles Clapisson, Thomas Bachelot, Sylvie Chabaud, Christine Bardin-dit-Courageot, Chantal Rigal, Cathy Biota, Agathe Bajard, Nicolas Pasqual, Jean-Yves Blay, Christophe Caux, Christine Ménétrier-Caux,